Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis

Saved in:
Bibliographic Details
Published in:Pediatric allergy and immunology 2024-08, Vol.35 (8), p.e14217-n/a
Main Authors: Gagnon, Hugo, Nguyen, Cam‐Tu Émilie, Hatami, Afshin, Bégin, Philippe, Grzywacz, Kelly
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
case report
Child
dupilumab
eosinophilic
eosinophilic esophagitis
Eosinophilic Esophagitis - diagnosis
Eosinophilic Esophagitis - drug therapy
Esophagitis
Female
Humans
Leukocytes (eosinophilic)
Male
Neuropathy
pediatric
Pediatrics
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - diagnosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2787-d72160ef5898012210f9d237fc856449f8ef51b0c86db119fc56af009d6a4be3
container_end_page n/a
container_issue 8
container_start_page e14217
container_title Pediatric allergy and immunology
container_volume 35
creator Gagnon, Hugo
Nguyen, Cam‐Tu Émilie
Hatami, Afshin
Bégin, Philippe
Grzywacz, Kelly
description
doi_str_mv 10.1111/pai.14217
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3089882922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3097703259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2787-d72160ef5898012210f9d237fc856449f8ef51b0c86db119fc56af009d6a4be3</originalsourceid><addsrcrecordid>eNp1kLtOwzAUhi0EoqUw8AIoEgsMKb4ksT1WFZdKlWAoC4vl2E7rKk1CHIO68Qg8I0-CIYUBCS_H55xPn45-AE4RHKPwrhppxyjBiO6BISKcxwQStg-GkMM0zlBKB-DIuTWEiJIMHYIB4QjyhOIheHqsXowtbbWMZOS8a4zqjI60b2zpNzL_eHu3lfYqzCrj27qR3Wob2SpqjLaya62KTO1sVTerYAmNCz-5tJ11x-CgkKUzJ7s6Aoub68X0Lp7f386mk3msMGU01hSjDJoiZZxBhDGCBdeY0EKxNEsSXrCwQzlULNM5QrxQaSYLCLnOZJIbMgIXvbZp62dvXCc21ilTlrIytXeCwCBmmGMc0PM_6Lr2bRWOCxSnFBKc8kBd9pRqa-daU4imtRvZbgWC4itvEfIW33kH9mxn9PnG6F_yJ-AAXPXAqy3N9n-TeJjMeuUnI0OLAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097703259</pqid></control><display><type>article</type><title>Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Gagnon, Hugo ; Nguyen, Cam‐Tu Émilie ; Hatami, Afshin ; Bégin, Philippe ; Grzywacz, Kelly</creator><creatorcontrib>Gagnon, Hugo ; Nguyen, Cam‐Tu Émilie ; Hatami, Afshin ; Bégin, Philippe ; Grzywacz, Kelly</creatorcontrib><identifier>ISSN: 0905-6157</identifier><identifier>ISSN: 1399-3038</identifier><identifier>EISSN: 1399-3038</identifier><identifier>DOI: 10.1111/pai.14217</identifier><identifier>PMID: 39109472</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibodies, Monoclonal, Humanized - adverse effects ; Antibodies, Monoclonal, Humanized - therapeutic use ; case report ; Child ; dupilumab ; eosinophilic ; eosinophilic esophagitis ; Eosinophilic Esophagitis - diagnosis ; Eosinophilic Esophagitis - drug therapy ; Esophagitis ; Female ; Humans ; Leukocytes (eosinophilic) ; Male ; Neuropathy ; pediatric ; Pediatrics ; Peripheral Nervous System Diseases - chemically induced ; Peripheral Nervous System Diseases - diagnosis</subject><ispartof>Pediatric allergy and immunology, 2024-08, Vol.35 (8), p.e14217-n/a</ispartof><rights>2024 European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2024 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2787-d72160ef5898012210f9d237fc856449f8ef51b0c86db119fc56af009d6a4be3</cites><orcidid>0009-0005-9564-9121</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39109472$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gagnon, Hugo</creatorcontrib><creatorcontrib>Nguyen, Cam‐Tu Émilie</creatorcontrib><creatorcontrib>Hatami, Afshin</creatorcontrib><creatorcontrib>Bégin, Philippe</creatorcontrib><creatorcontrib>Grzywacz, Kelly</creatorcontrib><title>Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis</title><title>Pediatric allergy and immunology</title><addtitle>Pediatr Allergy Immunol</addtitle><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>case report</subject><subject>Child</subject><subject>dupilumab</subject><subject>eosinophilic</subject><subject>eosinophilic esophagitis</subject><subject>Eosinophilic Esophagitis - diagnosis</subject><subject>Eosinophilic Esophagitis - drug therapy</subject><subject>Esophagitis</subject><subject>Female</subject><subject>Humans</subject><subject>Leukocytes (eosinophilic)</subject><subject>Male</subject><subject>Neuropathy</subject><subject>pediatric</subject><subject>Pediatrics</subject><subject>Peripheral Nervous System Diseases - chemically induced</subject><subject>Peripheral Nervous System Diseases - diagnosis</subject><issn>0905-6157</issn><issn>1399-3038</issn><issn>1399-3038</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kLtOwzAUhi0EoqUw8AIoEgsMKb4ksT1WFZdKlWAoC4vl2E7rKk1CHIO68Qg8I0-CIYUBCS_H55xPn45-AE4RHKPwrhppxyjBiO6BISKcxwQStg-GkMM0zlBKB-DIuTWEiJIMHYIB4QjyhOIheHqsXowtbbWMZOS8a4zqjI60b2zpNzL_eHu3lfYqzCrj27qR3Wob2SpqjLaya62KTO1sVTerYAmNCz-5tJ11x-CgkKUzJ7s6Aoub68X0Lp7f386mk3msMGU01hSjDJoiZZxBhDGCBdeY0EKxNEsSXrCwQzlULNM5QrxQaSYLCLnOZJIbMgIXvbZp62dvXCc21ilTlrIytXeCwCBmmGMc0PM_6Lr2bRWOCxSnFBKc8kBd9pRqa-daU4imtRvZbgWC4itvEfIW33kH9mxn9PnG6F_yJ-AAXPXAqy3N9n-TeJjMeuUnI0OLAA</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Gagnon, Hugo</creator><creator>Nguyen, Cam‐Tu Émilie</creator><creator>Hatami, Afshin</creator><creator>Bégin, Philippe</creator><creator>Grzywacz, Kelly</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0005-9564-9121</orcidid></search><sort><creationdate>202408</creationdate><title>Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis</title><author>Gagnon, Hugo ; Nguyen, Cam‐Tu Émilie ; Hatami, Afshin ; Bégin, Philippe ; Grzywacz, Kelly</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2787-d72160ef5898012210f9d237fc856449f8ef51b0c86db119fc56af009d6a4be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>case report</topic><topic>Child</topic><topic>dupilumab</topic><topic>eosinophilic</topic><topic>eosinophilic esophagitis</topic><topic>Eosinophilic Esophagitis - diagnosis</topic><topic>Eosinophilic Esophagitis - drug therapy</topic><topic>Esophagitis</topic><topic>Female</topic><topic>Humans</topic><topic>Leukocytes (eosinophilic)</topic><topic>Male</topic><topic>Neuropathy</topic><topic>pediatric</topic><topic>Pediatrics</topic><topic>Peripheral Nervous System Diseases - chemically induced</topic><topic>Peripheral Nervous System Diseases - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gagnon, Hugo</creatorcontrib><creatorcontrib>Nguyen, Cam‐Tu Émilie</creatorcontrib><creatorcontrib>Hatami, Afshin</creatorcontrib><creatorcontrib>Bégin, Philippe</creatorcontrib><creatorcontrib>Grzywacz, Kelly</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric allergy and immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gagnon, Hugo</au><au>Nguyen, Cam‐Tu Émilie</au><au>Hatami, Afshin</au><au>Bégin, Philippe</au><au>Grzywacz, Kelly</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis</atitle><jtitle>Pediatric allergy and immunology</jtitle><addtitle>Pediatr Allergy Immunol</addtitle><date>2024-08</date><risdate>2024</risdate><volume>35</volume><issue>8</issue><spage>e14217</spage><epage>n/a</epage><pages>e14217-n/a</pages><issn>0905-6157</issn><issn>1399-3038</issn><eissn>1399-3038</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39109472</pmid><doi>10.1111/pai.14217</doi><tpages>3</tpages><orcidid>https://orcid.org/0009-0005-9564-9121</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0905-6157
ispartof Pediatric allergy and immunology, 2024-08, Vol.35 (8), p.e14217-n/a
issn 0905-6157
1399-3038
1399-3038
language eng
recordid cdi_proquest_miscellaneous_3089882922
source Wiley-Blackwell Read & Publish Collection
subjects Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
case report
Child
dupilumab
eosinophilic
eosinophilic esophagitis
Eosinophilic Esophagitis - diagnosis
Eosinophilic Esophagitis - drug therapy
Esophagitis
Female
Humans
Leukocytes (eosinophilic)
Male
Neuropathy
pediatric
Pediatrics
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - diagnosis
title Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A54%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unveiling%20a%20suspected%20dupilumab%E2%80%90induced%20neuropathy%20in%20pediatric%20eosinophilic%20esophagitis&rft.jtitle=Pediatric%20allergy%20and%20immunology&rft.au=Gagnon,%20Hugo&rft.date=2024-08&rft.volume=35&rft.issue=8&rft.spage=e14217&rft.epage=n/a&rft.pages=e14217-n/a&rft.issn=0905-6157&rft.eissn=1399-3038&rft_id=info:doi/10.1111/pai.14217&rft_dat=%3Cproquest_cross%3E3097703259%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2787-d72160ef5898012210f9d237fc856449f8ef51b0c86db119fc56af009d6a4be3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3097703259&rft_id=info:pmid/39109472&rfr_iscdi=true